A multidisciplinary team of more than 250 scientists operates from Reading, England, under FDA approval, MHRA certification, and UKAS accreditation. Testing is organised by molecule type as well as by development phase, so a client can bring a small molecule, a biologic, a vaccine, a veterinary medicine, a consumer healthcare product, or a cell and gene therapy from research through clinical development to commercial release. GMP and CMC work covers lot release, environmental monitoring, and pharmacopeial testing, and a rapid mycoplasma screening and detection service was added for cell-based products. A Priority Response Service handles urgent investigations, and an Innovation Hub supports method development. RSSL also runs a substantial food and consumer goods business, including nutritional testing backed by a 1.2 million pound investment, allergen management, and packaging and contact materials work. Its training arm delivers Qualified Person, lead auditor, GDP and Responsible Person, ATMP, and validation courses, and a 2025 partnership with ERBC extends the offer toward end-to-end drug development.
RSSL
Reading Scientific Services Ltd (RSSL) is a leading multidisciplinary contract laboratory providing crucial scientific analysis, consultancy, and training services to the pharmaceutical, biopharmaceutical, and healthcare industries. Specializing in analytical chemistry, physical characterization, stability testing, and contaminant identification, RSSL ensures product safety, quality, and strict regulatory compliance.
